---
title: "12 Health Care Stocks Moving In Wednesday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294264018.md"
description: "In Wednesday's after-market session, several healthcare stocks saw significant movement. Gainers included Nuwellis (+40.2%), Onconetix (+27.46%), and Corcept Therapeutics (+19.05%). Losers featured Teladoc Health (-24.3%) and Inovio Pharmaceuticals (-20.25%). Many of these price swings were driven by the release of Q2 earnings reports."
datetime: "2026-07-29T21:06:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294264018.md)
  - [en](https://longbridge.com/en/news/294264018.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294264018.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Wednesday's After-Market Session

### Gainers

-   **Nuwellis** (NASDAQ:NUWE) stock rose 40.2% to $2.65 during Wednesday's after-market session.
-   **Onconetix** (NASDAQ:ONCO) shares moved upwards by 27.46% to $0.96. The company's market cap stands at $3.0 million.
-   **Corcept Therapeutics** (NASDAQ:CORT) stock increased by 19.05% to $110.66. The market value of their outstanding shares is at $10.1 billion. As per the news, the Q2 earnings report came out today.
-   **Aspire Biopharma Holdings** (NASDAQ:ASBP) stock increased by 14.08% to $6.4. The company's market cap stands at $9.3 million.
-   **Myriad Genetics** (NASDAQ:MYGN) stock rose 13.29% to $5.71. The market value of their outstanding shares is at $502.4 million.
-   **China SXT Pharmaceuticals** (NASDAQ:SXTC) shares rose 12.76% to $0.06. The company's market cap stands at $2.2 million.

### Losers

-   **Teladoc Health** (NYSE:TDOC) shares fell 24.3% to $6.95 during Wednesday's after-market session. The company's market cap stands at $1.6 billion. As per the press release, Q2 earnings came out today.
-   **Inovio Pharmaceuticals** (NASDAQ:INO) stock fell 20.25% to $0.83. The market value of their outstanding shares is at $84.7 million.
-   **SciSparc** (NASDAQ:SPRC) shares fell 15.63% to $7.67. The company's market cap stands at $3.0 million.
-   **Biodexa Pharmaceuticals** (NASDAQ:BDRX) stock decreased by 12.77% to $1.26. The company's market cap stands at $1.3 million.
-   **TransCode Therapeutics** (NASDAQ:RNAZ) shares declined by 10.87% to $4.51. The market value of their outstanding shares is at $5.2 million.
-   **Citius Pharmaceuticals** (NASDAQ:CTXR) stock decreased by 10.02% to $0.51. The market value of their outstanding shares is at $13.6 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [CORT.US](https://longbridge.com/en/quote/CORT.US.md)
- [TDOC.US](https://longbridge.com/en/quote/TDOC.US.md)
- [NUWE.US](https://longbridge.com/en/quote/NUWE.US.md)
- [ONCO.US](https://longbridge.com/en/quote/ONCO.US.md)
- [INO.US](https://longbridge.com/en/quote/INO.US.md)
- [ASBP.US](https://longbridge.com/en/quote/ASBP.US.md)
- [MYGN.US](https://longbridge.com/en/quote/MYGN.US.md)
- [SXTC.US](https://longbridge.com/en/quote/SXTC.US.md)
- [SPRC.US](https://longbridge.com/en/quote/SPRC.US.md)
- [BDRX.US](https://longbridge.com/en/quote/BDRX.US.md)
- [RNAZ.US](https://longbridge.com/en/quote/RNAZ.US.md)
- [CTXR.US](https://longbridge.com/en/quote/CTXR.US.md)
- [ASBPW.US](https://longbridge.com/en/quote/ASBPW.US.md)

## Related News & Research

- [Analyst Maintains Buy Rating on Teladoc with Unchanged $10.50 Price Target Amid Strategic Transition and New CFO Appointment](https://longbridge.com/en/news/297585950.md)
- [Empowered Funds LLC Invests $5.76 Million in Teladoc Health, Inc. $TDOC](https://longbridge.com/en/news/297483011.md)
- [09:01 ETHealthcare Is Moving Into the Home. Home Accessibility Now Has a Validated Score.](https://longbridge.com/en/news/297656740.md)
- [Sanctuary Advisors LLC Invests $808,000 in Corcept Therapeutics Incorporated $CORT](https://longbridge.com/en/news/297398480.md)
- [Akebia Therapeutics holds investor meetings at Wells Fargo Healthcare Conference](https://longbridge.com/en/news/297649009.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**